Tocilizumab en pacientes COVID-19: evaluación del perfil de seguridad en una indicación off label

Saved in:
Bibliographic Details
Published in:Revista medíca de Chile 2022-04, Vol.150 (4), p.431-438
Main Authors: Severino, Nicolás, Gutiérrez, Waldo, Fuenzalida, Tamara, Iturra, Pablo, González, Antonio
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1021-ef0169cce24c840d20dc0094a2ef9d91316973f37464ba84a01459b79aa4ee453
cites
container_end_page 438
container_issue 4
container_start_page 431
container_title Revista medíca de Chile
container_volume 150
creator Severino, Nicolás
Gutiérrez, Waldo
Fuenzalida, Tamara
Iturra, Pablo
González, Antonio
description
doi_str_mv 10.4067/S0034-98872022000400431
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_4067_S0034_98872022000400431</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_4067_S0034_98872022000400431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1021-ef0169cce24c840d20dc0094a2ef9d91316973f37464ba84a01459b79aa4ee453</originalsourceid><addsrcrecordid>eNplkE1OwzAQhb0AiVI4A75AYPzTOGaHyl-lSl1Q2EYTe4yM3DSKCRJciyNwMVKo2CA9aZ7em5nFx9iZgHMNpbl4AFC6sFVlJEgJAHqUEgds8lccseOcXwCkKUU1YW69dTHFj2GDDaeWd-gita-U-Xz1tLguhL3k9IZpGPOvz5Z7SryjPsQ0Wp7peeijR787HVrksfXR7Ve3IfCEDaUTdhgwZTrdzyl7vL1Zz--L5epuMb9aFk6AFAUFEKV1jqR2lQYvwTsAq1FSsN4KNbZGBWV0qRusNILQM9sYi6iJ9ExNmfn96_ptzj2FuuvjBvv3WkC941P_8Kn_8VHf-2tbOQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Tocilizumab en pacientes COVID-19: evaluación del perfil de seguridad en una indicación off label</title><source>SciELO</source><creator>Severino, Nicolás ; Gutiérrez, Waldo ; Fuenzalida, Tamara ; Iturra, Pablo ; González, Antonio</creator><creatorcontrib>Severino, Nicolás ; Gutiérrez, Waldo ; Fuenzalida, Tamara ; Iturra, Pablo ; González, Antonio</creatorcontrib><identifier>ISSN: 0034-9887</identifier><identifier>DOI: 10.4067/S0034-98872022000400431</identifier><language>eng</language><ispartof>Revista medíca de Chile, 2022-04, Vol.150 (4), p.431-438</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1021-ef0169cce24c840d20dc0094a2ef9d91316973f37464ba84a01459b79aa4ee453</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Severino, Nicolás</creatorcontrib><creatorcontrib>Gutiérrez, Waldo</creatorcontrib><creatorcontrib>Fuenzalida, Tamara</creatorcontrib><creatorcontrib>Iturra, Pablo</creatorcontrib><creatorcontrib>González, Antonio</creatorcontrib><title>Tocilizumab en pacientes COVID-19: evaluación del perfil de seguridad en una indicación off label</title><title>Revista medíca de Chile</title><issn>0034-9887</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNplkE1OwzAQhb0AiVI4A75AYPzTOGaHyl-lSl1Q2EYTe4yM3DSKCRJciyNwMVKo2CA9aZ7em5nFx9iZgHMNpbl4AFC6sFVlJEgJAHqUEgds8lccseOcXwCkKUU1YW69dTHFj2GDDaeWd-gita-U-Xz1tLguhL3k9IZpGPOvz5Z7SryjPsQ0Wp7peeijR787HVrksfXR7Ve3IfCEDaUTdhgwZTrdzyl7vL1Zz--L5epuMb9aFk6AFAUFEKV1jqR2lQYvwTsAq1FSsN4KNbZGBWV0qRusNILQM9sYi6iJ9ExNmfn96_ptzj2FuuvjBvv3WkC941P_8Kn_8VHf-2tbOQ</recordid><startdate>202204</startdate><enddate>202204</enddate><creator>Severino, Nicolás</creator><creator>Gutiérrez, Waldo</creator><creator>Fuenzalida, Tamara</creator><creator>Iturra, Pablo</creator><creator>González, Antonio</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202204</creationdate><title>Tocilizumab en pacientes COVID-19: evaluación del perfil de seguridad en una indicación off label</title><author>Severino, Nicolás ; Gutiérrez, Waldo ; Fuenzalida, Tamara ; Iturra, Pablo ; González, Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1021-ef0169cce24c840d20dc0094a2ef9d91316973f37464ba84a01459b79aa4ee453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Severino, Nicolás</creatorcontrib><creatorcontrib>Gutiérrez, Waldo</creatorcontrib><creatorcontrib>Fuenzalida, Tamara</creatorcontrib><creatorcontrib>Iturra, Pablo</creatorcontrib><creatorcontrib>González, Antonio</creatorcontrib><collection>CrossRef</collection><jtitle>Revista medíca de Chile</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Severino, Nicolás</au><au>Gutiérrez, Waldo</au><au>Fuenzalida, Tamara</au><au>Iturra, Pablo</au><au>González, Antonio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tocilizumab en pacientes COVID-19: evaluación del perfil de seguridad en una indicación off label</atitle><jtitle>Revista medíca de Chile</jtitle><date>2022-04</date><risdate>2022</risdate><volume>150</volume><issue>4</issue><spage>431</spage><epage>438</epage><pages>431-438</pages><issn>0034-9887</issn><doi>10.4067/S0034-98872022000400431</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0034-9887
ispartof Revista medíca de Chile, 2022-04, Vol.150 (4), p.431-438
issn 0034-9887
language eng
recordid cdi_crossref_primary_10_4067_S0034_98872022000400431
source SciELO
title Tocilizumab en pacientes COVID-19: evaluación del perfil de seguridad en una indicación off label
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T22%3A21%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tocilizumab%20en%20pacientes%20COVID-19:%20evaluaci%C3%B3n%20del%20perfil%20de%20seguridad%20en%20una%20indicaci%C3%B3n%20off%20label&rft.jtitle=Revista%20med%C3%ADca%20de%20Chile&rft.au=Severino,%20Nicol%C3%A1s&rft.date=2022-04&rft.volume=150&rft.issue=4&rft.spage=431&rft.epage=438&rft.pages=431-438&rft.issn=0034-9887&rft_id=info:doi/10.4067/S0034-98872022000400431&rft_dat=%3Ccrossref%3E10_4067_S0034_98872022000400431%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1021-ef0169cce24c840d20dc0094a2ef9d91316973f37464ba84a01459b79aa4ee453%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true